Early-stage technology development to improve collection, handling, processing, preservation, storage, and quality assessment of cancer-relevant biospecimens. Part of NCI’s IMAT program; high-risk, high-impact concepts encouraged.
Eligibility Criteria:
-
Universities, nonprofits, for-profits, governments; foreign organizations eligible (foreign components allowed).
-
PD/PI with appropriate expertise; eRA Commons/Grants.gov registrations required.
-
Multidisciplinary teams encouraged; clinical trials not allowed.
Funding Details:
-
Mechanism: R61 (exploratory/developmental).
-
Budget: up to USD 150,000 USD direct costs/year.
-
Project period: up to 3 years.
-
Expected FY26 funding: 4 awards (1M USD total).
Deadline:
-
Due: October 3, 2025 (5:00 PM local time).
-
FOA: RFA-CA-25-003.
Where to Go for Further Information:
- Program details.
-
Scientific/Research: Kelly Crotty, PhD — [email protected].
-
General help: [email protected].